Overview

Docetaxel in Node Positive Adjuvant Breast Cancer

Status:
Completed

Trial end date:
2010-01-01

Target enrollment:

Participant gender:

Summary

The purpose of this study was to compare disease-free survival after treatment with docetaxel in combination with doxorubicin and cyclophosphamide to 5-fluorouracil in combination with doxorubicin and cyclophosphamide in operable breast cancer patients with positive axillary lymph nodes.

Phase:

Phase 3

Details

Lead Sponsor:

Sanofi

Collaborator:

Cancer International Research Group (CIRG)

Treatments:

Cyclophosphamide
Docetaxel
Doxorubicin
Fluorouracil
Liposomal doxorubicin